Literature DB >> 3141545

Quantitation of plasma apolipoprotein A-I using two monoclonal antibodies in an enzyme-linked immunosorbent assay.

D M Hogle1, R S Smith, L K Curtiss.   

Abstract

A rapid sandwich enzyme-linked immunosorbent assay (ELISA) for the quantitation of human apolipoprotein (apo) A-I was developed. The assay uses a pair of noncompeting purified monoclonal antibodies to detect apoA-I in plasma. The antibodies used in this assay were selected because they bind greater than 90% of radioiodinated high density lipoprotein (HDL), they identify "fresh" nondeamidated epitopes on apoA-I, and they have comparable binding affinities for isolated HDL and HDL in plasma. The assay was standardized with a plasma secondary standard composed of lyophilized human serum. The assay was used to measure the apoA-I levels in normal subjects, patients with coronary artery disease, and patients with familial hypercholesterolemia. The results indicate that certain monoclonal antibodies can be used to reliably measure plasma levels of apoA-I in diverse groups of subjects.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3141545

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  4 in total

1.  Familial hypobetalipoproteinemia caused by a mutation in the apolipoprotein B gene that results in a truncated species of apolipoprotein B (B-31). A unique mutation that helps to define the portion of the apolipoprotein B molecule required for the formation of buoyant, triglyceride-rich lipoproteins.

Authors:  S G Young; S T Hubl; R S Smith; S M Snyder; J F Terdiman
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

2.  Early inflammatory and metabolic changes in association with AGTR1 polymorphisms in prehypertensive subjects.

Authors:  Maple M Fung; Fangwen Rao; Sameer Poddar; Manjula Mahata; Srikrishna Khandrika; Sushil K Mahata; Daniel T O'Connor
Journal:  Am J Hypertens       Date:  2010-09-23       Impact factor: 2.689

3.  Altered epitope expression of human interstitial fluid apolipoprotein A-I reduces its ability to activate lecithin cholesterol acyl transferase.

Authors:  L Wong; L K Curtiss; J Huang; C J Mann; B Maldonado; P S Roheim
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

4.  Apolipoprotein (apo) E inhibits the capacity of monosodium urate crystals to stimulate neutrophils. Characterization of intraarticular apo E and demonstration of apo E binding to urate crystals in vivo.

Authors:  R A Terkeltaub; C A Dyer; J Martin; L K Curtiss
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.